BioLegend purchases Covance’s antibody products, manufacturing business
Antibody and reagent developer and manufacturer BioLegend on Tuesday acquired Covance’s antibody services unit for an undisclosed sum.
Antibody and reagent developer and manufacturer BioLegend on Tuesday acquired Covance’s antibody services unit for an undisclosed sum.
Biopharmas scaling-up production should use fluid dynamics to make better predictions about bioreactor performance according to one expert, who says engineers can use it to test multiple configurations more rapidly.
Sanofi and Regeneron may overtake Roche and Astrazeneca at the head of the increasingly monoclonal antibody (mAb) dominated asthma treatment market according to an industry analyst.
The environmental impact of single-use biosystems remains lower than stainless steel despite difficulties in the disposal of bioreactor bags, says Sartorius.